Annette C. Kuesel

World Health Organization — Switzerland

Medicine · Health Sciences

28h-index3.6kcitations69works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parasitic Diseases Research and Treatment(40), Parasites and Host Interactions(24), Parasite Biology and Host Interactions(20), Insects and Parasite Interactions(13), Advanced MRI Techniques and Applications(10)

Publications69 total

The WHO IRIS APOC Collection: an electronic resource of the OCP and APOC experience and data to inform onchocerciasis elimination strategies
International Health·2026Open Access
Reduction in Onchocerca volvulus infection prevalence and intensity in Logo Health Zone in Ituri, Democratic Republic of the Congo, in the absence of interventions: Results of screening for clinical trials of moxidectin vs. ivermectin in 2010 and 2021-2023
2025· 1 citedOpen Access
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study
Parasites & Vectors·2025Open Access
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: Results of an open-label pharmacokinetic and safety study in an onchocerciasis endemic area in Ghana
2025Open Access
An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination
Clinical Infectious Diseases·2024· 6 citedOpen Access
Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in <i>Loa loa</i>–Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities
Open Forum Infectious Diseases·2024· 4 citedOpen Access
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
Parasites & Vectors·2024· 4 citedOpen Access
Genome-based tools for onchocerciasis elimination: utility of the mitochondrial genome for delineating Onchocerca volvulus transmission zones
International Journal for Parasitology·2023· 12 citedOpen Access
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use
Parasites & Vectors·2023· 19 citedOpen Access
Procedure for Handling and Storage of Onchocerca volvulus Microfilariae Obtained from Skin Snips for Downstream Genetic Work
Tropical Medicine and Infectious Disease·2023· 2 citedOpen Access
Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
Philosophical Transactions of the Royal Society B Biological Sciences·2023· 27 citedOpen Access
Assessing Onchocerca volvulus Intensity of Infection and Genetic Diversity Using Mitochondrial Genome Sequencing of Single Microfilariae Obtained before and after Ivermectin Treatment
Pathogens·2023· 7 citedOpen Access
O. volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: Results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
Research Square (Research Square)·2023· 1 citedOpen Access
The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration
Parasites & Vectors·2023· 28 citedOpen Access
Impact of human movement between hypo- and hyperendemic areas on sustainability of elimination of <i>Onchocerca volvulus</i> transmission
2023· 5 citedOpen Access
Safety and Short-Term Efficacy of a Single Dose of 2 mg Moxidectin in &lt;i&gt;Loa loa&lt;/i&gt; Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial with Ascending Microfilarial Densities
SSRN Electronic Journal·2023Open Access
Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children
Parasites & Vectors·2022· 8 citedOpen Access
Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection
PLoS neglected tropical diseases·2022· 145 citedOpen Access
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
PLoS neglected tropical diseases·2022· 152 citedOpen Access
Effect of a single dose of 8 mg moxidectin or 150 µg/kg ivermectin on <i>O. volvulus</i> skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection
2022· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Nicholas Opoku(13), Simon K. Attah(11), María‐Gloria Basáñez(8), George Olipoh(6), Christine Halleux(6), Martin Walker(6), Warwick N. Grant(6), Didier Bakajika(5), Eric M. Kanza(5), Hayford Howard(5), Germain Mambandu(5), Maurice M. Nigo(5), Mupenzi Mumbere(5), Kambale Kataliko(5), Sampson Asare(5), Michel Vaillant(5), Shannon M. Hedtke(5), William Halliday(4), Ian C. P. Smith(4), Piero Olliaro(4)